Platelet-derived CD154: Ultrastructural localization and clinical correlation in organ transplantation

A. H. Charafeddine, E. J. Kim, D. M. Maynard, H. Yi, T. A. Weaver, Meral Gunay-Aygun, M. Russell, W. A. Gahl, A. D. Kirk

Research output: Contribution to journalArticle

Abstract

CD154 is an immunostimulatory ligand for CD40 that markedly influences alloimmunity. Its presence in platelets suggests that its release and subsequent immune effects are driven by trauma and thus could be relevant following organ transplantation. However, the release of platelet derived CD154 and its consequences have not been investigated in a clinical transplant setting. To better characterize the relationship between platelet activation and CD154 release, we investigated CD154 release by platelets obtained from normal individuals, and patients with two genetic defects that influence platelet granule development. Using these unique patient populations and immune-electron microscopy, we confirmed that CD154 was an alpha granule and not a cell surface protein, and thereafter optimized the methods for its in vivo measurement in humans. We then investigated plasma CD154 levels in kidney and liver transplant recipients and found no evidence that CD154 levels fluctuated systemically as a result of kidney or liver transplant procedures. Paradoxically, we found that kidney transplant patients had significantly lower systemic CD154 levels during episodes of rejection. These data suggest that the immune effects of CD154 are likely mediated through local and not systemic mechanisms, and discourage the use of CD154 as a peripheral biomarker in organ transplantation.

Original languageEnglish (US)
Pages (from-to)3143-3151
Number of pages9
JournalAmerican Journal of Transplantation
Volume12
Issue number11
DOIs
StatePublished - Nov 2012
Externally publishedYes

Fingerprint

Organ Transplantation
Blood Platelets
Transplants
Kidney
CD40 Ligand
Liver
Platelet Activation
Electron Microscopy
Membrane Proteins
Biomarkers
Wounds and Injuries
Population

Keywords

  • Costimulation
  • platelets
  • trauma

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Platelet-derived CD154 : Ultrastructural localization and clinical correlation in organ transplantation. / Charafeddine, A. H.; Kim, E. J.; Maynard, D. M.; Yi, H.; Weaver, T. A.; Gunay-Aygun, Meral; Russell, M.; Gahl, W. A.; Kirk, A. D.

In: American Journal of Transplantation, Vol. 12, No. 11, 11.2012, p. 3143-3151.

Research output: Contribution to journalArticle

Charafeddine, AH, Kim, EJ, Maynard, DM, Yi, H, Weaver, TA, Gunay-Aygun, M, Russell, M, Gahl, WA & Kirk, AD 2012, 'Platelet-derived CD154: Ultrastructural localization and clinical correlation in organ transplantation', American Journal of Transplantation, vol. 12, no. 11, pp. 3143-3151. https://doi.org/10.1111/j.1600-6143.2012.04241.x
Charafeddine, A. H. ; Kim, E. J. ; Maynard, D. M. ; Yi, H. ; Weaver, T. A. ; Gunay-Aygun, Meral ; Russell, M. ; Gahl, W. A. ; Kirk, A. D. / Platelet-derived CD154 : Ultrastructural localization and clinical correlation in organ transplantation. In: American Journal of Transplantation. 2012 ; Vol. 12, No. 11. pp. 3143-3151.
@article{2003591f5c5f425daa6e282dc25675ad,
title = "Platelet-derived CD154: Ultrastructural localization and clinical correlation in organ transplantation",
abstract = "CD154 is an immunostimulatory ligand for CD40 that markedly influences alloimmunity. Its presence in platelets suggests that its release and subsequent immune effects are driven by trauma and thus could be relevant following organ transplantation. However, the release of platelet derived CD154 and its consequences have not been investigated in a clinical transplant setting. To better characterize the relationship between platelet activation and CD154 release, we investigated CD154 release by platelets obtained from normal individuals, and patients with two genetic defects that influence platelet granule development. Using these unique patient populations and immune-electron microscopy, we confirmed that CD154 was an alpha granule and not a cell surface protein, and thereafter optimized the methods for its in vivo measurement in humans. We then investigated plasma CD154 levels in kidney and liver transplant recipients and found no evidence that CD154 levels fluctuated systemically as a result of kidney or liver transplant procedures. Paradoxically, we found that kidney transplant patients had significantly lower systemic CD154 levels during episodes of rejection. These data suggest that the immune effects of CD154 are likely mediated through local and not systemic mechanisms, and discourage the use of CD154 as a peripheral biomarker in organ transplantation.",
keywords = "Costimulation, platelets, trauma",
author = "Charafeddine, {A. H.} and Kim, {E. J.} and Maynard, {D. M.} and H. Yi and Weaver, {T. A.} and Meral Gunay-Aygun and M. Russell and Gahl, {W. A.} and Kirk, {A. D.}",
year = "2012",
month = "11",
doi = "10.1111/j.1600-6143.2012.04241.x",
language = "English (US)",
volume = "12",
pages = "3143--3151",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Platelet-derived CD154

T2 - Ultrastructural localization and clinical correlation in organ transplantation

AU - Charafeddine, A. H.

AU - Kim, E. J.

AU - Maynard, D. M.

AU - Yi, H.

AU - Weaver, T. A.

AU - Gunay-Aygun, Meral

AU - Russell, M.

AU - Gahl, W. A.

AU - Kirk, A. D.

PY - 2012/11

Y1 - 2012/11

N2 - CD154 is an immunostimulatory ligand for CD40 that markedly influences alloimmunity. Its presence in platelets suggests that its release and subsequent immune effects are driven by trauma and thus could be relevant following organ transplantation. However, the release of platelet derived CD154 and its consequences have not been investigated in a clinical transplant setting. To better characterize the relationship between platelet activation and CD154 release, we investigated CD154 release by platelets obtained from normal individuals, and patients with two genetic defects that influence platelet granule development. Using these unique patient populations and immune-electron microscopy, we confirmed that CD154 was an alpha granule and not a cell surface protein, and thereafter optimized the methods for its in vivo measurement in humans. We then investigated plasma CD154 levels in kidney and liver transplant recipients and found no evidence that CD154 levels fluctuated systemically as a result of kidney or liver transplant procedures. Paradoxically, we found that kidney transplant patients had significantly lower systemic CD154 levels during episodes of rejection. These data suggest that the immune effects of CD154 are likely mediated through local and not systemic mechanisms, and discourage the use of CD154 as a peripheral biomarker in organ transplantation.

AB - CD154 is an immunostimulatory ligand for CD40 that markedly influences alloimmunity. Its presence in platelets suggests that its release and subsequent immune effects are driven by trauma and thus could be relevant following organ transplantation. However, the release of platelet derived CD154 and its consequences have not been investigated in a clinical transplant setting. To better characterize the relationship between platelet activation and CD154 release, we investigated CD154 release by platelets obtained from normal individuals, and patients with two genetic defects that influence platelet granule development. Using these unique patient populations and immune-electron microscopy, we confirmed that CD154 was an alpha granule and not a cell surface protein, and thereafter optimized the methods for its in vivo measurement in humans. We then investigated plasma CD154 levels in kidney and liver transplant recipients and found no evidence that CD154 levels fluctuated systemically as a result of kidney or liver transplant procedures. Paradoxically, we found that kidney transplant patients had significantly lower systemic CD154 levels during episodes of rejection. These data suggest that the immune effects of CD154 are likely mediated through local and not systemic mechanisms, and discourage the use of CD154 as a peripheral biomarker in organ transplantation.

KW - Costimulation

KW - platelets

KW - trauma

UR - http://www.scopus.com/inward/record.url?scp=84868193077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868193077&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2012.04241.x

DO - 10.1111/j.1600-6143.2012.04241.x

M3 - Article

C2 - 22947105

AN - SCOPUS:84868193077

VL - 12

SP - 3143

EP - 3151

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 11

ER -